Utilizing cell-free DNA to predict risk of developing brain metastases in patients with metastatic breast cancer.

Vidula, Neelima; Niemierko, Andrzej; Hesler, Katherine; Ryan, Lianne; Moy, Beverly; Isakoff, Steven; Ellisen, Leif; Juric, Dejan; Bardia, Aditya

Vidula, Neelima; Niemierko, Andrzej; Hesler, Katherine; Ryan, Lianne; Moy, Beverly; Isakoff, Steven; Ellisen, Leif; Juric, Dejan; Bardia, Aditya.

Afiliación

Vidula N; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA. nvidula@mgh.harvard.edu.
Niemierko A; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
Hesler K; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
Ryan L; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
Moy B; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
Isakoff S; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
Ellisen L; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
Juric D; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
Bardia A; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.

NPJ Breast Cancer ; 9(1): 29, 2023 Apr 19.

Article en En | MEDLINE | ID: mdl-37076495

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: NPJ Breast Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google